Ollie's Bargain Outlet

OLLI

Market cap $5.8B

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Ollie's thrives on disruption, turning excess inventory and bankruptcies into fuel for steady expansion. Five Below proved it can adapt fast, leaning into trends and still growing despite heavy tariff exposure.

Consumers under financial pressure are flocking to deep-discount retailers, giving Ollie's a natural demand tailwind. The company's closeout, ever-changing inventory model creates a “treasure hunt” experience that keeps shoppers loyal and engaged.

Ollie's Bargain Outlet (NASDAQ:OLLI) has been upgraded to a ‘Buy' rating by Jefferies analysts, who cited the company's strong market position, traffic-driven model, and potential for long-term unit growth. The firm set a new price target of $130, up from $120, noting that Ollie's currently trades at roughly a 7x P/E discount to Five Below (FIVE), compared with a historical discount of about 1x.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Ollie's Bargain Outlet (NASDAQ:OLLI) has been caught in a meaningful selloff, but Wells Fargo analyst Edward Kelly sees the weakness as an opportunity.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

The Fund rebounded and outperformed the Russell 2000 ® Growth Index in the fourth quarter. Boot Barn's revenues and earnings handily exceeded estimates, with greater transaction volumes and new store openings. Abivax reported strong clinical trial results for its obefazimod treatment to address ulcerative colitis in a longer lasting manner.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Ollie's Bargain Outlet's NASDAQ: OLLI stock price downtrend is over. The Q4 2025 results are in, and they reaffirmed a robust outlook.